FIELD: organic chemistry.
SUBSTANCE: method for production of target compounds of formula IA having high protein kinase inhibitor activity includes interaction of corresponding compound of formula IIA with compound of formula R2XH.
EFFECT: mew compounds with protein kinase inhibitor activity.
14 cl, 6 dwg, 102 ex
Title | Year | Author | Number |
---|---|---|---|
TREATING IMANITIB-RESISTANT LEUKAEMIA WITH USE OF 4-AMINOQUINOLINE-3-CARBONITRYL | 2008 |
|
RU2464026C2 |
METHOD OF OBTAINING 4-AMINO-3-QUINOLINECARBONITRYLS | 2004 |
|
RU2345069C2 |
SUBSTITUTED 3-CYANOQUINOLINES | 1998 |
|
RU2202551C2 |
QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
ROUTES OF APPLICATION OF PHOSPHODIESTERASE INHIBITORS | 2020 |
|
RU2795503C2 |
TRICYCLIC DICARBONYL DERIVATIVES AND DRUG BASED ON SAID | 1995 |
|
RU2145606C1 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
3-AMINO-PYRIDINE DERIVATIVES FOR TREATING METABOLIC DISORDERS | 2007 |
|
RU2460729C2 |
NOVEL DERIVATIVES OF 2,6-DIAMINOPYRIDIN-3-ONE | 2005 |
|
RU2385866C2 |
DERIVATIVES OF PYRIDINE AND QUINOLINE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, USING COMPOUNDS FOR TREATMENT OF DPP-IV-ASSOCIATED DISEASES | 2003 |
|
RU2285693C2 |
Authors
Dates
2007-10-27—Published
2003-04-29—Filed